If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Field Trials

26 Nov 2008 07:00

RNS Number : 9440I
Plant Health Care PLC
26 November 2008
 



26 November 2008

Plant Health Care plc ("Plant Health Care" or the "Company")

Results of the ASA Sponsored N-Hibit Seed Treatment Program

Plant Health Care (AIM: PHC.L), a leading provider of natural products to the agriculture and landscape industries and  the American Soybean Association ("ASA") are pleased to announce that the "N-Hibit® Seed Treatment Satisfaction Guarantee" program during the 2008 growing season was an unqualified success.

The results of the N-Hibit Seed Treatment program over 17 replicated trial sites, ranging from Ohio to Nebraska, produced N-Hibit-treated yields averaging 62.0 bushels/acre compared to the untreated control average of 58.6 bushels/acre. This represents a yield increase of 3.4 bushels/acre or 5.8 per cent. As a consequence, less than 3 per cent. of the acreage treated with N-Hibit resulted in requests for refunds under the Seed Treatment Satisfaction Guarantee Program. The combined effect of nematode reduction and enhanced plant growth are the primary reasons for these excellent results.

ASA President John Hoffman, a soybean producer from WaterlooIowa, commented:

"ASA partnered with PHC on the project because part of ASA's mission is to help identify new ways for ASA members to maximize soybean yield and profitability. N-Hibit's ability to reduce SCN damage and boost overall plant health is consistent with that mission, so ASA worked with PHC to make our members aware of the Satisfaction Guarantee program."

Rick Rice, Plant Health Care Director, Sales & MarketingUSA Agricultural Division stated:

"We wanted growers to share our confidence, and the Satisfaction Guarantee program assured them of a full refund of the purchase price paid for N-Hibit if they weren't fully satisfied with its performance on treated acreage. With a better than 97 percent success rate and the relationships we have developed with all the farmers involved in the program, we couldn't be more pleased." 

The active ingredient in N-Hibit is harpin protein, which stimulates the same plant growth response that occurs when a plant experiences stress. The induced response results in a healthier plant and a reduction in the number of nematodes that host on the roots. Harpin proteins do not enter the plant. They bind with the plant's external harpin protein receptors, which are present on both seed and foliage. After the proteins initiate the plant's natural self defense and growth systems, they harmlessly disintegrate. For more information about PHC, please visit www.planthealthcare.com.

  For more information contact: 

John Hoffman, ASA President +001 (319) 233 9480

John Brady, Plant Health Care plc CEO +001 603 525 3702

Evolution Securities Limited +44 (0)20 7071 4300

Tim Worlledge / Tim Redfern

Tavistock Communications Limited +44 (0)20 7920 3150

Jeremy Carey / Matt Ridsdale

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAAFSAFXPFAE
Date   Source Headline
29th Aug 200810:37 amRNSNotice of Results
15th Aug 200812:36 pmRNSHolding(s) in Company
1st Aug 20081:08 pmRNSTotal Voting Rights
7th Jul 200812:21 pmRNSHolding(s) in Company
4th Jul 20087:00 amRNSProduct Update
3rd Jul 20087:00 amRNSCleantech Index
2nd Jul 200812:07 pmRNSStock Award
1st Jul 200811:49 amRNSTotal Voting Rights
17th Jun 20085:36 pmRNSAdditional Listing
17th Jun 20083:47 pmRNSNotification of Shareholding
13th Jun 20082:07 pmRNSHolding(s) in Company
12th Jun 20087:00 amRNSField Trials
6th Jun 200812:59 pmRNSResult of Annual General Meet
6th Jun 20087:00 amRNSAGM Statement and Trading Upd
3rd Jun 20087:30 amRNSField Trials
2nd Jun 20089:50 amRNSTotal Voting Rights
13th May 200812:41 pmRNSDirectors' dealings and addit
1st May 20082:39 pmRNSAdditional Listing
30th Apr 20086:11 pmRNSAnnual Report and Accounts
30th Apr 200811:24 amRNSTotal Voting Rights
28th Apr 20088:09 amRNSNew Trials
14th Apr 20085:39 pmRNSDirector/PDMR Shareholding
2nd Apr 20086:18 pmRNSDirector/PDMR Shareholding
1st Apr 20087:01 amRNSDirectorate Change
1st Apr 20087:01 amRNSTotal Voting Rights
31st Mar 20087:02 amRNSFinal Results
12th Mar 20084:40 pmRNSAdditional Listing
29th Feb 20084:59 pmRNSTotal Voting Rights
21st Feb 20087:01 amRNSStatement re Monsanto
18th Feb 20088:00 amRNSASA Partnership
12th Feb 20085:14 pmRNSAdditional Listing
31st Jan 20084:03 pmRNSTotal Voting Rights
21st Jan 20087:01 amRNSRe Agreement
21st Jan 20087:01 amRNSProduct Update
21st Jan 20087:01 amRNSTrading Statement
14th Jan 200811:57 amRNSNotification of Shareholding
9th Jan 20089:00 amRNSField Trial Update
31st Dec 200712:51 pmRNSTotal Voting Rights
19th Dec 20079:00 amRNSNotification of Shareholding
3rd Dec 20073:00 pmRNSTotal Voting Rights
20th Nov 20079:15 amRNSAdditional Listing
1st Nov 200712:16 pmRNSTotal Voting Rights
24th Oct 20076:13 pmRNSStock Award
22nd Oct 200710:35 amRNSNotification of Shareholding
5th Oct 20073:56 pmRNSNotification of Shareholding
2nd Oct 20074:46 pmRNSNotification of Shareholding
2nd Oct 200712:59 pmRNSTotal Voting Rights
1st Oct 20075:54 pmRNSNotification of Shareholding
1st Oct 20075:51 pmRNSNotification of Shareholding
1st Oct 20073:22 pmRNSDoc re. Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.